Treatment combating multi-drug resistant TB posts positive results
March 27, 2017Research and Development, Sales and Marketing Infectex, Sequella, tuberculosis
Infectex, a Russian portfolio company of Maxwell Biotech Venture Fund, announced that it had found positive results from its latest …
AstraZeneca’s medicine approved under China’s Priority Review
March 27, 2017Sales and Marketing AstraZeneca, Tagrisso, lung cancer
AstraZeneca has been boosted by the news that its drug, Tagrisso, has become its first drug to be approved under …
Five worrying facts about fake medicine
March 27, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Fake medicine, counterfeit medicine, falsified medicine
One million people die from fake drugs every year, with the worst continent being Africa where a suspected 200,000 die …
Merck KGaA and Pfizer enter the immunotherapy market with Bavencio
March 27, 2017Sales and Marketing Bavencio, Merck KGaA, Pfizer
Merck KGaA and Pfizer have won approval for the fourth immunotherapy treatment to enter the market, with an indication in …
Lilly promises $850 million investment in message to White House
March 27, 2017Manufacturing and Production, Sales and Marketing Eli Lilly, President trump, lilly
Eli Lilly’s latest press release indicated that it would be spending $850 million in developing its worldwide US operations, particularly …
Top Ten most popular articles on Pharmafile.com this week
March 24, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten
With the weekend on the horizon and a new issue of Pharmafocus hitting press, we review the most read, shared …
Cancer Research UK announces £10m pancreatic cancer project
March 24, 2017Medical Communications, Research and Development Cancer Research UK, Pancreatic cancer
Cancer Research UK has revealed a £10 million investment into PRECISION-Panc, a pancreatic cancer-focused project which aims to improve patient …
A patent analytics study of the Australian pharmaceutical industry
March 24, 2017Medical Communications Australia, patent, pharmaceutical
This report provides an analysis of the Australian pharmaceutical and biopharmaceutical industry through the lens of patents. By using the …
Research found to reverse signs of ageing in mice
March 24, 2017Medical Communications, Research and Development Aging
A new study has emerged that reveals another clue into the process of ageing and how, on a cellular level, …
Sanofi looks to close $1 billion deal Flexion
March 24, 2017Medical Communications, Sales and Marketing Sanofi, flexion therapeutics, osteo
According to reports emerging, Sanofi may be on the verge of closing a deal with Burlington-based biotech, Flexion Therapeutics. The …
DrugDev signs up George Masoura as Vice President of Business Development
March 23, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment
DrugDev has announced the appointment of George Masoura who has joined the company as Vice President, Business Development, Europe to …
Advent reportedly backs out of bid for Pfizer’s Brazil plant
March 23, 2017Sales and Marketing Brazil, Pfizer, generics
It has been reported that Advent International Corp has pulled out of bidding for Pfizer’s stake in Brazilian generics manufacturer, …
Injectable drug market to grow to $625 billion worldwide by 2021
March 23, 2017Sales and Marketing injectable drugs, injectables
New data released by intelligence firm MarketsandMarkets indicates that the global injectable drug market is set to reach $625 billion …
Drug prices set to increase on ‘essential medicines’ list in India
March 23, 2017Sales and Marketing Indian
The annual review of drug prices will see the price of drugs, on the National List of Essential Medicines, increase …
GSK and Regeneron partner with Biobank to analyse 500,000 genetic profiles
March 23, 2017Research and Development Biobank, GSK, Regeneron
GlaxoSmithKline and Regeneron Pharmaceuticals are to band together in a joint effort with UK Biobank – “the world’s most detailed …
Shire’s drug picked up from Baxalta given fast track designation
March 23, 2017Research and Development, Sales and Marketing Shire, rare diseases
Shire has announced that its drug, SHP655, has received a fast track designation based on pre-clinical trials and positive results …
FDA approves first Parkinson’s treatment in a decade
March 22, 2017Research and Development, Sales and Marketing FDA, Parkinson's, Xadago
The FDA has approved Xadago (safinamide) as a supplementary treatment for Parkinson’s in patients currently taking levodopa/carbidopa and who are …
Alternative treatment cures rare blood disease for first time
March 22, 2017Research and Development congenital dyserythropoietic anaemia
A Chicago man has become the first person ever documented to be cured of congenital dyserythropoietic anaemia (CDA), a rare …
GSK begins £92 million expansion of UK site
March 22, 2017Manufacturing and Production, Research and Development GSK, UK
GSK has officially broken ground on the expansion of its site in County Durham. The expanded site will be an …
Novartis heart failure drug sinks at Phase 3 trials
March 22, 2017Research and Development Acute heart failure, Novartis, serelaxin
Novartis’ serelaxin was once thought to be the major hope for its cardiovascular pipeline – analysts projected it to become …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
